GlassScriptPhysician profile
Jaime Dickerson
NPI 1265881171
$6,299.59
in general payments reported to CMS, 2019-2025
9 companies · $42.17 in 2025
The $42.17 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,016 · 2022: $40.19 · 2023: $202 · 2025: $42.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.84 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,000.00 | 2021 | |
| Astellas Pharma US INC | $129.38 | 2023 | Myrbetriq, Veozah |
| Hologic Sales and Service, LLC | $39.53 | 2023-2025 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $38.19 | 2023-2025 | |
| Pfizer INC. | $22.82 | 2023 | |
| Organon LLC | $21.41 | 2022 | |
| Axonics, INC. | $18.78 | 2022 | |
| Coopersurgical, INC. | $15.56 | 2021 | |
| Guard Medical INC. | $13.92 | 2023 | Npseal Large, Npseal (5), Npseal Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.